Prostate Cancer study: Apple Cider Vinegar
Official title Akkermansia Muciniphilia and Metabolic Side Effects of ADT
ClinicalTrials.gov ID: NCT05802121
What this study is testing
What is Apple Cider Vinegar?
an investigational oral supplement being studied as a potential treatment for prostate cancer
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether taking oral acetate can increase A. muciniphilia in stool and be safe for you.
- Who it's for
- You may be able to join if you have metastatic castration‑sensitive prostate cancer.
- What's involved
- You would take an oral acetate supplement each day and provide stool samples. You would also attend regular clinic visits to check safety and side effects.
- Time commitment
- The study lasts a few months and requires several clinic visits during that time.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Men ≥18 years of age with histologically-proven metastatic castration-sensitive prostate adenocarcinoma planned to receive ADT (TNM stage Tany, Nany...
- Age less than 18
- Primary neuroendocrine prostate cancer
- Treatment with ADT within the year leading up to enrolment
- Planned or concurrent use of chromium supplementation for the study duration
See the full eligibility criteria
- Men ≥18 years of age with histologically-proven metastatic castration-sensitive prostate adenocarcinoma planned to receive ADT (TNM stage Tany, Nany, M1) (see Appendix I).
- Age less than 18
- Primary neuroendocrine prostate cancer
- Treatment with ADT within the year leading up to enrolment
- Planned or concurrent use of chromium supplementation for the study duration
- Planned or concurrent use of apple cider vinegar supplementation for the study duration
- Unable to provide informed consent or unable to understand or read the English language (unless accompanied by an interpreter)
- Inadequate liver function (\>2x upper limit of normal)
- Any other condition, chronic disease, or lifestyle factor, that, in the opinion of the Qualified Investigator, may adversely affect the participant's ability to complete the study or its measures or pose significant...
- Use of antibiotics that cannot be discontinued for a washout period and remain off them for the duration of the trial
The study team makes the final eligibility decision.
Where it is enrolling
- London, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at London, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.